Product Description.:
Watson, 243 or 244 or P1
tablet , multi-colored , round round
12 light blue (243), 9 light yellow-green (244), 7 orange (P1)
Provides a continuous oral contraceptive regimen of 7 light blue tablets, 9 light yellow-green tablets, 5 more light blue tablets, and then 7 orange tablets. Each light blue tablet contains norethindrone 0.5 mg and ethinyl estradiol 0.035 mg, each light yellow-green tablet contains norethindrone 1 mg and ethinyl estradiol 0.035 mg, and each orange tablet contains inert ingredients.
Norethindrone is a potent progestational agent with the chemical name 17-Hydroxy-19-nor-17α-pregn-4-en-20-yn-3-one. Ethinyl estradiol is an estrogen with the chemical name 19-Nor-17α-pregna-1,3,5 (10)-trien-20-yne-3,17-diol.
INDICATIONS AND USAGE
Oral contraceptives are indicated for the prevention of pregnancy in women who elect to use this product as a method of contraception.
Oral contraceptive products such as Norinyl, which contain 50 mcg of estrogen, should not be used unless medically indicated.
Oral contraceptives are highly effective. Table I lists the typical accidental pregnancy rates for users of combination oral contraceptives and other methods of contraception.1 The efficacy of these contraceptive methods, except sterilization, depends upon the reliability with which they are used. Correct and consistent use of methods can result in lower failure rates.
CONTRAINDICATIONS
Oral contraceptives should not be used in women who have the following conditions:
*
Thrombophlebitis or thromboembolic disorders
*
A past history of deep vein thrombophlebitis or thromboembolic disorders
*
Cerebral vascular or coronary artery disease
*
Known or suspected carcinoma of the breast
*
Carcinoma of the endometrium or other known or suspected estrogen-dependent neoplasia
*
Undiagnosed abnormal genital bleeding
*
Cholestatic jaundice of pregnancy or jaundice with prior pill use
*
Hepatic adenomas, carcinomas or benign liver tumors
*
Known or suspected pregnancy